Evidence map›Paper›PMID 32254022›Full record

ArticleeLife2020

Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditions.

Anna Plana-Bonamaisó, Santiago López-Begines, David Fernández-Justel, Alexandra Junza, Ariadna Soler-Tapia, Jordi Andilla, Pablo Loza-Alvarez, Jose Luis Rosa, Esther Miralles, Isidre Casals and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Rhodopsin mislocalization drives ciliary dysregulation in a novel autosomal dominant retinitis pigmentosa knock-in mouse model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. A journey into the regulatory secrets of theFrontiers in pharmacology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Anna Plana-BonamaisóDepartment of Physiological Sciences, School of Medicine, Campus Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.
Santiago López-BeginesDepartment of Physiological Sciences, School of Medicine, Campus Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.ORCID 0000-0001-8809-8919
David Fernández-JustelMetabolic Engineering Group, Department of Microbiology and Genetics. University of Salamanca, Salamanca, Spain.ORCID 0000-0001-5728-2756
Alexandra JunzaCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain.
Ariadna Soler-TapiaDepartment of Physiological Sciences, School of Medicine, Campus Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.
Jordi AndillaICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Castelldefels, Spain.
Pablo Loza-AlvarezICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, Castelldefels, Spain.
Jose Luis RosaDepartment of Physiological Sciences, School of Medicine, Campus Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.
Esther MirallesCentres Cientifics i Tecnològics (CCiTUB), University of Barcelona, Parc Científic de Barcelona, Barcelona, Spain.
Isidre CasalsCentres Cientifics i Tecnològics (CCiTUB), University of Barcelona, Parc Científic de Barcelona, Barcelona, Spain.
Oscar YanesCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Madrid, Spain.
Pedro de la VillaPhysiology Unit, Dept of Systems Biology, School of Medicine, University of Alcalá, Madrid, Spain.
Ruben M BueyMetabolic Engineering Group, Department of Microbiology and Genetics. University of Salamanca, Salamanca, Spain.ORCID 0000-0003-1263-0221
Ana MéndezDepartment of Physiological Sciences, School of Medicine, Campus Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.ORCID 0000-0001-6393-1644
Universitat de Barcelona · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESInstitut d'Investigació Biomédica de Bellvitge · ESInstitute of Photonic Sciences · ESUniversidad de Salamanca · ESUniversidad de Alcalá · ES

Funding

Centres de Recerca de Catalunya CERCA Institutional SupportFundacio La Marató 20141730Fundació la Marató de TV3 20141730Fundación Ramón Areces XVII Edition Rare DiseasesFundació Privada Cellex ICFO Institutional SupportInstituto de Salud Carlos III PI18/00754Junta de Castilla y León Graduate student fellowshipLaser Lab Europe 654148Ministerio de Economía y Competitividad BFU2016-79237-PMinisterio de Economía y Competitividad BFU2016-80583-RMinisterio de Economía y Competitividad SEV-2015-0522
6 · The paper itself

Abstract

We report the in vivo regulation of Inosine-5´-monophosphate dehydrogenase 1 (IMPDH1) in the retina. IMPDH1 catalyzes the rate-limiting step in the de novo synthesis of guanine nucleotides, impacting the cellular pools of GMP, GDP and GTP. Guanine nucleotide homeostasis is central to photoreceptor cells, where cGMP is the signal transducing molecule in the light response. Mutations in IMPDH1 lead to inherited blindness. We unveil a light-dependent phosphorylation of retinal IMPDH1 at Thr

Indexed as

LightProtein Processing, Post-TranslationalAdenosine TriphosphateAnimalsBiochemical PhenomenaGene Expression RegulationGuanosine TriphosphateHomeostasisIMP DehydrogenaseMiceMice, Inbred C57BLMutationPhosphorylationPhotic StimulationPhotoreceptor CellsRetinaAdenosine TriphosphateGuanosine TriphosphateIMP DehydrogenaseIMPDH1, mousebiochemistrycGMPchemical biologyenzymologyIMPDH1mouseneurosciencephotoreceptor metabolismphotoreceptor physiologyretinal dystrophy

Identifiers

PMID32254022
PMCPMC7176436
OpenAlexW3014323330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.